See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Merck & Co., Inc. (MRK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Merck & Co., Inc. (MRK) - free report >>
Image: Bigstock
S&P Set to Open Above 3000
Futures are pointing to a big spike off the open, with the S&P trading over the 3000 level, or about 2%. If the gains hold, we would open above the 200-day moving average, a psychological win for the bulls. This would mark the first time since early March that the S&P has traded above this important technical level.
The bulls should have enough power to squeeze those traders that bet against the recent rally, but there will likely be extra supply to churn through first. Expect a fight at this S&P 3000 level.
S&P Futures Trading Levels
The S&P futures currently sit at 3007. Support levels for the day will be 3001 and 2976
The upside should see some resistance at 3018, but 3060 is possible over the next few days.
The current environment trending higher.
Three Stocks to Watch
NVAX- The company has initiated it Phase 1/2 Clinical trial of its COVID-19 Vaccine. Results will be expected in early July, which has the stock gapping 20% higher premarket.
AZO- The company reported earnings this morning, seeing a beat on both the top and bottom line. The beat is the tenth in a row and has the stock trading 1.7% higher on low pre-market volume.
MRK – Merck and IAVI will collaborate to develop a vaccine for COVID-19. The stock was up 4.5% in pre-market trade.
Zacks’ Single Best Pick to Double
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.
Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.
Click Here, See It Free >>